Hong Sun is the Director of Business Analysis for Oncology (TKI & Prostate Cancer) at Bayer Pharmaceuticals. Previously, Hong held various roles at Boehringer Ingelheim Pharmaceuticals Inc., including Senior Analyst in Marketing Decision Science and Manager of Business Analysis. At Bayer, Hong advanced through positions such as Associate Director of Secondary Data Analytics and Deputy Director before assuming the current directorial role. Hong's extensive experience in business analytics spans multiple therapeutic areas, demonstrating a strong background in data-driven decision-making in the pharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices